Company intelligence / Profile preview
VULM
- Ownership
- Private
- Development stage
- Other
Overview
VULM is an established Slovak pharmaceutical company with a global presence. It has been active since 1972 and focuses on research, development, and production of drugs (various forms), medical devices, food supplements, and cosmetics. The company operates modern EU GMP-compliant facilities for manufacturing non-sterile liquid, semi-solid/topical, and solid drug forms. Clinical results are not detailed publicly as the focus is on commercialized products rather than novel clinical-stage assets.
- Therapeutic areas
- Other
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on VULM.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on VULM.